Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE 2020-21 Annual Report Analysis
Wed, 31 Mar

TTK HEALTHCARE has announced its results for the year ended March 2021. Let us have a look at the detailed performance review of the company during FY20-21.

TTK HEALTHCARE Income Statement Analysis

  • Operating income during the year fell 1.4% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 51.9% YoY during the fiscal. Operating profit margins witnessed a fall and down at 6.8% in FY21 as against 4.4% in FY20.
  • Depreciation charges decreased by 4.6% and finance costs decreased by 32.0% YoY, respectively.
  • Other income grew by 14.0% YoY.
  • Net profit for the year grew by 277.0% YoY.
  • Net profit margins during the year grew from 1.9% in FY20 to 7.3% in FY21.

TTK HEALTHCARE Income Statement 2020-21

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Net Sales Rs m 6,458 6,365 -1.4%
Other income Rs m 88 100 14.0%
Total Revenues Rs m 6,545 6,465 -1.2%
Gross profit Rs m 283 430 51.9%
Depreciation Rs m 144 137 -4.6%
Interest Rs m 33 22 -32.0%
Profit before tax Rs m 194 371 90.7%
Tax Rs m 71 -94 -232.1%
Profit after tax Rs m 123 464 277.0%
Gross profit margin % 4.4 6.8
Effective tax rate % 36.6 -25.3
Net profit margin % 1.9 7.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...

TTK HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY21 stood at Rs 2 billion as compared to Rs 2 billion in FY20, thereby witnessing an increase of 10.1%.
  • Current assets rose 26% and stood at Rs 4 billion, while fixed assets fell 13% and stood at Rs 1 billion in FY21.
  • Overall, the total assets and liabilities for FY21 stood at Rs 5 billion as against Rs 4 billion during FY20, thereby witnessing a growth of 14%.

TTK HEALTHCARE Balance Sheet as on March 2021

No. of Mths Year Ending 12 Mar-20* 12 Mar-21* % Change
Networth Rs m 2,490 2,946 18.3
 
Current Liabilities Rs m 1,715 1,888 10.1
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 4,270 4,878 14.2
 
Current assets Rs m 2,980 3,752 25.9
Fixed Assets Rs m 1,290 1,126 -12.7
Total Assets Rs m 4,270 4,878 14.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



TTK HEALTHCARE Cash Flow Statement Analysis

  • TTK HEALTHCARE's cash flow from operating activities (CFO) during FY21 stood at Rs 964 million, an improvement of 386.0% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY21 stood at Rs -772 million, an improvement of 480.8% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY21 stood at Rs -172 million on a YoY basis.
  • Overall, net cash flows for the company during FY21 stood at Rs 20 million from the Rs -36 million net cash flows seen during FY20.

TTK HEALTHCARE Cash Flow Statement 2020-21

Particulars No. of months 12 12 % Change
Year Ending Mar-20 Mar-21
Cash Flow from Operating Activities Rs m 198 964 386.0%
Cash Flow from Investing Activities Rs m -133 -772 -
Cash Flow from Financing Activities Rs m -102 -172 -
Net Cash Flow Rs m -36 20 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for TTK HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 32.9, an improvement from the EPS of Rs 8.7 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 494.6, stands at 15.0 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 2.4 times, while the price to sales ratio stands at 1.1 times.
  • The company's price to cash flow (P/CF) ratio stood at 11.5 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Sales per share (Unadj.) Rs 457.0 450.5
TTM Earnings per share Rs 8.7 32.9
Diluted earnings per share Rs 8.7 32.9
Price to Cash Flow x 17.3 11.5
TTM P/E ratio x 37.5 15.0
Price / Book Value ratio x 2.8 2.4
Market Cap Rs m 6,992 6,945
Dividends per share (Unadj.) Rs 3.0 6.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for TTK HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 2.0x during FY21, from 1.7x during FY20. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 17.7x during FY21, from 6.9x during FY20. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 15.8% during FY21, from 4.9% during FY21. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 13.3% during FY21, from 9.1% during FY20. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 10.0% during FY21, from 3.7% during FY20. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-20* 12 Mar-21*
Current ratio x 1.7 2.0
Debtors’ Days Days 434 343
Interest coverage x 6.9 17.7
Debt to equity ratio x 0.0 0.0
Return on assets % 3.7 10.0
Return on equity % 4.9 15.8
Return on capital employed % 9.1 13.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how TTK HEALTHCARE has performed over the last 5 years, please visit here.

TTK HEALTHCARE Share Price Performance

Over the last one year, TTK HEALTHCARE share price has moved up from Rs 327.0 to Rs 494.6, registering a gain of Rs 167.7 or around 51.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,328.2 (up 0.4%). Over the last one year it has moved up from 12,148.6 to 21,328.2, a gain of 9,180 points (up 75.6%).

Overall, the S&P BSE SENSEX is up 74.1% over the year.

(To know more, check out historical annual results for TTK HEALTHCARE and quarterly results for TTK HEALTHCARE)

Annual Report FAQs

What is the current share price of TTK HEALTHCARE?

TTK HEALTHCARE currently trades at Rs 1,587.8 per share. You can check out the latest share price performance of TTK HEALTHCARE here...

What was the revenue of TTK HEALTHCARE in FY21? How does it compare to earlier years?

The revenues of TTK HEALTHCARE stood at Rs 6,465 m in FY21, which was down -1.2% compared to Rs 6,545 m reported in FY20.

TTK HEALTHCARE's revenue has grown from Rs 5,335 m in FY17 to Rs 6,465 m in FY21.

Over the past 5 years, the revenue of TTK HEALTHCARE has grown at a CAGR of 4.9%.

What was the net profit of TTK HEALTHCARE in FY21? How does it compare to earlier years?

The net profit of TTK HEALTHCARE stood at Rs 464 m in FY21, which was up 277.0% compared to Rs 123 m reported in FY20.

This compares to a net profit of Rs 244 m in FY19 and a net profit of Rs 182 m in FY18.

Over the past 5 years, TTK HEALTHCARE net profit has grown at a CAGR of 25.5%.

What does the cash flow statement of TTK HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of TTK HEALTHCARE reveals:

  • Cash flow from operations increased in FY21 and stood at Rs 964 m as compared to Rs 198 m in FY20.
  • Cash flow from investments decreased in FY21 and stood at Rs -772 m as compared to Rs -133 m in FY20.
  • Cash flow from financial activity decreased in FY21 and stood at Rs -172 m as compared to Rs -102 m in FY20.

Here's the cash flow statement of TTK HEALTHCARE for the past 5 years.

(Rs m)FY17FY18FY19FY20FY21
From Operations178253173198964
From Investments53-22697-133-772
From Financial Activity-229-72-307-102-172
Net Cashflow1-41-38-3620

What does the Key Ratio analysis of TTK HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of TTK HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and down at 6.8% in FY21 as against 4.4% in FY20.
  • Net profit margins grew from 1.9% in FY20 to 7.3% in FY21.
  • Debt to Equity ratio for FY21 stood at 0.0 as compared to 0.0 in FY20.

Here's the ratio/financial analysis of TTK HEALTHCARE for the past 5 years.

 FY17FY18FY19FY20FY21
Operating Profit Margin (%)7.37.47.94.46.8
Net Profit Margin (%)3.63.13.91.97.3
Debt to Equity Ratio (x)0.00.00.00.00.0

Read: Latest Annual Report Analysis of TTK HEALTHCARE

 

Equitymaster requests your view! Post a comment on "TTK HEALTHCARE 2020-21 Annual Report Analysis". Click here!